This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Inotek Pharmaceuticals Corporation
Drug Names(s): PJ-875, trabodenoson
Description: INO-8875 (formerly PJ-875) is a potent and highly selective activator of the adenosine 1 (A1) receptor. INO-8875 is thought to work by restoring trabecular meshwork outflow and may have a secondary mechanism of action of reducing aqueous humor production.
Pink Sheet Glaucoma's Changing Of The Guard
Additional information available to subscribers only: